Literature DB >> 16141765

Overactive bladder: epidemiology and social impact.

Andrea Tubaro1, Giovanni Palleschi.   

Abstract

PURPOSE OF REVIEW: Overactive bladder epidemiology is a rapidly evolving field. The new terminology of lower urinary tract function, introduced in 2002, modified the definitions of all four components of overactive bladder. In the same year, the lack of specific information on overactive bladder prevalence was identified and consequently new studies were launched and recently published. RECENT
FINDINGS: Following the new terminology, overactive bladder now includes both a purely sensory disorder and a condition related to an altered bladder behaviour. Studies conducted in selected countries and populations suggested comparable prevalence data worldwide, although the syndrome is considered to be underreported. 'Urge' is now considered the cornerstone symptom of overactive bladder. Recent epidemiological data confirm the increase in overactive bladder prevalence with age and suggest that most diet and lifestyle factors are not associated with the condition, with the exception of body mass index. Among the symptoms, urge and urinary incontinence were considered to be more significantly related to patients' quality of life compared with frequency and nocturia. The socioeconomic consequences of the overactive bladder syndrome were recently estimated in a large US study and a total cost of 12.6 billion US dollars was calculated.
SUMMARY: Specific data on overactive bladder epidemiology are now available, providing new evidence about its relevance as a clinical issue. Both wet and dry overactive bladder cause a significant reduction in quality of life. In our daily practice we have to consider that overactive bladder is frequently underreported as patients believe that no treatment is available and urinary incontinence is considered a natural consequence of aging.

Entities:  

Mesh:

Year:  2005        PMID: 16141765     DOI: 10.1097/01.gco.0000183529.26352.52

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  8 in total

Review 1.  Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure?

Authors:  Vik Khullar
Journal:  Int Urogynecol J       Date:  2011-10-20       Impact factor: 2.894

2.  Objective Evaluation of Overactive Bladder: Which Surveys Should I Use?

Authors:  Michael Shy; Sophie G Fletcher
Journal:  Curr Bladder Dysfunct Rep       Date:  2013-03-01

3.  The help-seeking by women with urinary incontinence in Brazil.

Authors:  Angela A N Rios; Jefferson R Cardoso; Marco Aurélio Freitas Rodrigues; Silvio Henrique Maia de Almeida
Journal:  Int Urogynecol J       Date:  2011-01-11       Impact factor: 2.894

4.  Prevalence, treatment and known risk factors of urinary incontinence and overactive bladder in the non-institutionalized Portuguese population.

Authors:  Sofia Correia; Paulo Dinis; Francisco Rolo; Nuno Lunet
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-08-14

5.  Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder.

Authors:  Franklin Chu; Neila Smith; Takeshi Uchida
Journal:  Curr Ther Res Clin Exp       Date:  2009-12

6.  Cholinergic Antagonists Combined with Electrical Stimulation or Bladder Training Treatments for Overactive Bladder in Female Adults: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yang Cao; Jianwei Lv; Chen Zhao; Jiayi Li; Jing Leng
Journal:  Clin Drug Investig       Date:  2016-10       Impact factor: 2.859

Review 7.  Social, economic, and health utility considerations in the treatment of overactive bladder.

Authors:  Emilio Sacco; Daniele Tienforti; Alessandro D'Addessi; Francesco Pinto; Marco Racioppi; Angelo Totaro; Daniele D'Agostino; Francesco Marangi; Pierfrancesco Bassi
Journal:  Open Access J Urol       Date:  2010-02-11

8.  Heart rate variability in overactive bladder experimental model.

Authors:  Lukasz Dobrek; Piotr Thor
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.